title: Intravenous pamidronate: evolution of an effective treatment strategy.
authors.affiliation: University of Manchester Bone Disease Research Centre, England.
authors.forename: D C
authors.initials: DC
authors.lastname: Anderson
authors.forename: P C
authors.initials: PC
authors.lastname: Richardson
authors.forename: J K
authors.initials: JK
authors.lastname: Brown
authors.forename: A J
authors.initials: AJ
authors.lastname: Freemont
authors.forename: S
authors.initials: S
authors.lastname: Hollis
authors.forename: J
authors.initials: J
authors.lastname: Denton
authors.forename: H M
authors.initials: HM
authors.lastname: Buckler
authors.forename: S
authors.initials: S
authors.lastname: Hargreaves
authors.forename: J A
authors.initials: JA
authors.lastname: Cantrill
mesh_terms: D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D004164:Diphosphonates / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007262:Infusions, Intravenous; D010001:Osteitis Deformans / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000652:urine; D000077268:Pamidronate; D011877:Radionuclide Imaging; D012074:Remission Induction; D012720:Severity of Illness Index
chemical_list: D004164:Diphosphonates; D000469:Alkaline Phosphatase; D000077268:Pamidronate; D006909:Hydroxyproline